Pre-hospital blood product transfusion and calcium management in the United Kingdom: a multicentre service evaluation

英国院前输血和钙管理:一项多中心服务评估

阅读:2

Abstract

BACKGROUND: Hypocalcaemia and hypercalcaemia are associated with increased morbidity and mortality in trauma patients. Although in-hospital calcium replacement protocols target normocalcaemia, UK pre-hospital services lack standardised calcium monitoring capabilities and demonstrate significant variation in calcium supplementation. No evidence-based guidelines exist for pre- and early in-hospital calcium administration in patients receiving blood product transfusion. This study characterises current UK pre-hospital calcium management in patients requiring blood transfusion prior to ionised calcium (iCa) measurement. METHODS: A multicentre pre-hospital service evaluation across five UK Helicopter Emergency Medicine Services (HEMS) from February to April 2024, including all adult trauma patients receiving pre-hospital blood transfusions. Data collected included baseline demographics, pre- and in-hospital blood products transfused, calcium dose and calcium measurement in the Emergency Department. The primary outcome was iCa on initial blood gas measurement. RESULTS: Fifty-eight patients were included, stratified by calcium levels on hospital arrival: 25 (43.1%) hypocalcaemic, 20 (34.5%) normocalcaemic, and 13 (22.4%) were hypercalcaemic. Most patients were male (84%) sustained blunt trauma (76%) and the overall median iCa was 1.14 mmol/L on first blood gas analysis. Pre-hospital calcium was given to 57%, with hypercalcaemic patients more likely to receive replacement. Normocalcaemic patients received fewer blood products overall. Increasing blood product administration was associated with lower calcium levels, especially in those not receiving pre-hospital calcium. CONCLUSION: Hypocalcaemia and hypercalcaemia were common. Calcium replacement protocols may under- or overtreat due to diverse injury patterns and baseline patient factors. Pre-hospital point-of-care testing (POCT) for iCa could help tailor treatment, especially in cases with longer times between injury and arrival at hospital. We demonstrate the feasibility of collecting comprehensive pre- and in-hospital data across multiple HEMS services to better inform future guidelines in patients with traumatic haemorrhage.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。